Lynda Charters

A study detailed at the 22nd EURETINA Congress in Hamburg, Germany, documented a spectrum of manifestations following COVID-19 infections in an otherwise immunocompetent patient presenting at a tertiary care center.

Product is forging a future in ocular regenerative procedures

The 22nd European Society of Retina Specialists Congress kicks off Thursday at the Congress Centre Hamburg in Hamburg, Germany.

The debate continues about the protective effect of eyeglasses against contracting the COVID-19 virus. Researchers from Denmark reported that their results were inconclusive regarding whether wearing eyeglasses is linked with a decreased risk of COVID-19 infections.

Edward J. Holland, MD, discusses how postoperative dry eye disease after refractive and cataract procedures may lead to patient dissatisfaction.

Reducing incidents can reduces cases of infection, transmission among physicians, clinicians.

The IOL has a hybrid design that combines the benefits of central extended depth-of-focus technology and multifocal technology that provides a continuous range of high-quality vision ranging from distance and intermediate and near vision to about 12 to 14 inches.

According to Sarah Van Tassel, MD, physicians may need to recognize issues and treat patients more holistically.

Audrey R. Talley Rostov, MD, discusses how patient education and hygiene is important for a positive outcome.

According to Alyson Hall, MD, factors can include vascular dysregulation, oxidative stress, autoimmunity and cytotoxicity.

George Waring IV, MD, FACS, points out that supplementation and customized procedures are in the offing.

According to researchers, functional assessments and education are critical to an early diagnosis.

Low-grade inflammation seems to be associated with baseline disease in inherited retinal dystrophies (IRDs), according to Christine N. Kay, MD, a surgeon at Vitreoretinal Associates, in Gainesville, Florida.

X-linked retinoschisis is a congenital disorder that results in visual impairment in boys at an early age. No treatment is currently available, and surgical repair fails in many cases.

In a study, investigators found that no characteristics of inflammatory bowel disease are related to ocular manifestations of the disease.

Industry leaders will come together Dec. 16-17 in Marco Island, Florida, to present the latest data and treatments.

A novel regimen may represent an improvement over current methods of handling postsurgical pain in procedures that require corneal epithelial debridement, according to investigators.

Symptoms in the eye may not be substantial in patients with COVID-19.

Investigators discuss the evolution of innovative technology for the hearing impaired and how vision can play a role.

Several issues may restimulate the virus in those patients with prior exposure.

The Grail study finds the device can offer positive outcomes for patients.

While the surgeons reported that the BW filter provided higher contrast during nucleus and viscous removal and posterior capsular polishing, they subjectively reported no significant advantage of using a BW filter.

According to the company, new imaging options presenting opportunity for better outcomes for patients.

Janet B. Serle, MD, discusses the pros and cons of various treatment options.

Physicians use a new administration method to treat patients diagnosed with noninfectious uveitis.